Related Experiment Video
Updated: May 11, 2026

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
Published on: April 5, 2017
Stability of rifampin in SyrSpend SF
Bridget Sorenson1, Paul Whaley
1Dynalabs, LLC, St. Louis, Missouri 63103, USA. bsorenson@dynalabs.us
Abstract:
Rifampin is a bactericidal antibiotic drug of the rifamycin group. It is a semisynthetic drug produced from the bacterium Streptomyces mediterranei. Rifampin is commonly manufactured in capsule, tablet, and syrup dosage solutions containing alcohol or sorbitol. The objective of this study was to determine the stability of rifampin in SyrSpend SF. The studied samples were compounded into 25-mg/mL suspensions and stored in low-actinic bottles at room temperature and refrigerated conditions. Samples were assayed at each time point out to 60 days by a stability-indicating high-performance liquid chromatography method. The method was validated for its specificity through forced-degradation studies. The sample remained within 90% to 110% of the initial concentration throughout the course of the study. Based on data collected, the beyond-use date of the preparation is at least 60 days when refrigerated or stored at room temperature and protected from light.
Insights
This study found that rifampin (a key antibiotic) suspensions are stable for at least 60 days. The drug maintained its concentration when stored at room temperature or refrigerated, protected from light.
Area of Science:
- Pharmaceutical Sciences
- Microbiology
Background:
- Rifampin is a crucial bactericidal antibiotic from the rifamycin group, derived from Streptomyces mediterranei.
- It is available in various dosage forms, including capsules, tablets, and syrups, often containing alcohol or sorbitol.
Purpose of the Study:
- To evaluate the stability of rifampin compounded into a 25-mg/mL oral suspension using SyrSpend SF.
- To establish a beyond-use date for this specific rifampin preparation.
Main Methods:
- Rifampin suspensions were prepared at 25 mg/mL and stored in low-actinic bottles under room temperature and refrigerated conditions.
- Stability was assessed over 60 days using a validated, stability-indicating high-performance liquid chromatography (HPLC) method, including forced-degradation studies.
Main Results:
- Rifampin concentration remained within 90% to 110% of the initial value throughout the 60-day study period.
- The drug demonstrated stability under both room temperature and refrigerated storage conditions when protected from light.
Conclusions:
- The compounded rifampin suspension in SyrSpend SF is stable for at least 60 days.
- A beyond-use date of 60 days is recommended for refrigerated or room temperature storage, provided the preparation is protected from light.
Related Concept Videos
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Drug Product Stability
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration

